Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Arati Desai, MD, MAS

Assistant Professor of Clinical Medicine
Attending, Inpatient Oncology Service, Hospital of the University of Pennsylvania
Co-Director, Brain Tumor Program, University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-307
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-349-8140
Fax: 215-662-7804
A.B. (English, Certificate in Women's Studies)
Princeton University, 1996.
M.D. (Medicine)
University of Kentucky College of Medicine, 2001.
M.A.S. (Advanced Studies in Clinical Research)
University of California, San Francisco, 2006.
Post-Graduate Training
Post-sophomore Fellowship in Pathology, University of Kentucky College of Medicine, 1998-1999.
Intern in Medicine, University of Texas Southwestern Medical Center, Parkland Memorial Hospital, 2001-2002.
Resident in Medicine, University of Texas Southwestern Medical Center, Parkland Memorial Hospital, 2002-2004.
Clinical Research Fellowship Program, University of California, San Francisco, 2004-2006.
Fellowship in Oncology, Johns Hopkins Hospital, Baltimore, MD, 2006-2009.
American Board of Internal Medicine, 2004.
ABIM, Medical Oncology, 2008.
ABIM, Hospice and Palliative Medicine, 2012.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

O'Rourke Donald M, *Nasrallah MacLean P, *Desai Arati, *Melenhorst Jan J, Mansfield Keith, Morrissette Jennifer J D, Martinez-Lage Maria, Brem Steven, Maloney Eileen, Shen Angela, Isaacs Randi, Mohan Suyash, Plesa Gabriela, Lacey Simon F, Navenot Jean-Marc, Zheng Zhaohui, Levine Bruce L, Okada Hideho, June Carl H, Brogdon Jennifer L, Maus Marcela V: A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma. Science Translational Medicine 9(399), Jul 2017 Notes: I am co-second author on this publication.

Nasrallah MacLean P, Nasrallah Ilya M, Prelack Marisa S, Johnson Margaret O, Lewis Travis B, Rubenstein Michael, Minturn Jane E, Desai Arati, Marcotte Paul, Santi Mariarita, Martinez-Lage Maria: 19-Year-Old Male with Headaches and a Possible Seizure. Brain pathology (Zurich, Switzerland) 27(4): 557-558, Jul 2017.

Holdhoff Matthias, Ye Xiaobu, Supko Jeffrey G, Nabors Louis B, Desai Arati S, Walbert Tobias, Lesser Glenn J, Read William L, Lieberman Frank S, Lodge Martin A, Leal Jeffrey, Fisher Joy D, Desideri Serena, Grossman Stuart A, Wahl Richard L, Schiff David: Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas. Neuro-oncology 19(6): 845-852, June 2017.

Lodge Martin A, Holdhoff Matthias, Leal Jeffrey P, Bag Asim K, Nabors L Burt, Mintz Akiva, Lesser Glenn J, Mankoff David A, Desai Arati S, Mountz James M, Lieberman Frank S, Fisher Joy D, Desideri Serena, Ye Xiaobu, Grossman Stuart A, Schiff David, Wahl Richard L: Repeatability of (18)F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 58(3): 393-398, Mar 2017.

Donald M. O'Rourke, MacLean Nasrallah, Jennifer J. Morrissette, Jan J. Melenhorst, Simon F. Lacey, Keith Mansfield, Maria Martinez-Lage, Arati Suvas Desai, Steven Brem, Eileen Maloney, Suyash Mohan, Sumei Wang, Gaurav Verma, Jean-Marc Navenot, Angela Shen, Zhaohui Zheng, Bruce Levine, Hideho Okada, Carl H. June, Marcela Valderrama Maus; University of Pennsylvania, Philadelphia, PA; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Novartis Institutes for Biomedical Research, Cambridge, MA; Novartis Pharma, Florham Park, NJ; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA; University of California, San Francisco, CA: Pilot study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII+ glioblastoma. ASCO Annual Meeting, Chicago, IL Journal of Clinical Oncology 34, 2016 (suppl; abstr 2061) 34, Jun 2016 Notes: "Poster Presentation"

Evans Sydney M, Putt Mary, Yang Xiang-Yang, Lustig Robert A, Martinez-Lage Maria, Williams Dewight, Desai Arati, Wolf Ronald, Brem Steven, Koch Cameron J: Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients. Journal of neuro-oncology Jan 2016.

S. Wang, M. Martinez-Lage, Y. Sakai, S. Chawla, S.G. Kim, M. Alonso-Basanta, R.A. Lustig, S. Brem, S. Mohan, R.L. Wolf, A. Desai,and H. Poptani : Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI American Journal of Neuroradiology 37: 28-36, 2016.

Steven Brem, Eric T. Wong, Arati Desai, Yi Fan, and Edward Pan: Angiogenesis and Brain Tumors: Scientific Principles, Current Therapy, and Future Directions. Youmans and Winn Neurological Surgery 7th Edition. Chapter 116. H. Richard Winn (eds.). Elsevier, 2016.

Donald O’Rourke, Arati Desai, Jennifer Morrissette, Maria Martinez-Lage, MacLean Nasrallah, Steven Brem, Eileen Maloney, Angela Shen, SuyashMohan, SumeiWang, GauravVerma, Simon Lacey, Jan Melenhorst, Jean-Marc Navenot, Zhaohui Zheng, Bruce Levine, HidehoOkada, Carl June, and Marcela Maus: PILOT STUDY OF T CELLS REDIRECTED TO EGFRvIII WITH A CHIMERIC ANTIGEN RECEPTOR IN PATIENTS WITH EGFRvIII1 GLIOBLASTOMA. Neuro-Oncology 17(IMCT-15): 107-112, Nov 2015 Notes: doi:10.1093/neuonc/nov218.15, "Poster Presentation"

Matthias Holdhoff, Martin A. Lodge, Asim K. Bag, L. Burt Nabors, Akiva Mintz, Glenn J. Lesser, David A. Mankoff, Arati S. Desai, Frank S. Lieberman, Jeffrey Leal, Joy D. Fisher, Serena Desideri, Xiaobu Ye, Stuart A. Grossman, David Schiff, and Richard L. Wahl: RESULTS OF EXPLORATORY 18F-FLT PET IMAGING IN TEN RECURRENT HIGH-GRADE GLIOMA PATIENTS TREATED WITH THE SELECTIVE T-TYPE CALCIUM CHANNEL BLOCKER MIBEFRADIL FOLLOWED BY TEMOZOLOMIDE (ABTC TRIAL 1101). Neuro-Oncology 17(NIMG-35), November 2015.

back to top
Last updated: 01/29/2018
The Trustees of the University of Pennsylvania
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration